Name

Medroxyprogesterone Acetate

Alternate Names

Alti-MPA
Amen
Curretab
Cycrin
Depcorlutin
Depo-Provera
Farlutin
Gestapuran
Lutopolar
Lutoral
Medroxypro-gesterone Acetate
Oragest
Perlutex
Proclim
Prodasone
Progestal
Provera
Proverone
Repromap
Repromix
Sirprogen
U-8839
Veramix

Abbreviations

DMPA
MAP
MPA

Category

Hormones and hormonal mechanisms

Subcategory

Progestin

NSC Number

026386
26386

Primary Site

Endometrial cancer
renal cancer

Histology

None

Remarks

A synthetic progestogen (progestin). FDA approved palliative uses in advanced endometrial carcinoma and advanced renal cell carcinoma; administered intramuscularly. This drug lessens the tumor burden allowing for surgical treatment. If given prior to surgical treatment, code as neo-adjuvant therapy. Also used orally in the treatment of secondary amenorrhea and functional uterine bleeding and as a contraceptive.

Coding

This drug should be coded
Glossary